SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-14-254520
Filing Date
2014-06-30
Accepted
2014-06-30 09:32:59
Documents
4
Group Members
PS MANAGEMENT GP, LLCWILLIAM A. ACKMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 TO SCHEDULE 13D d750342dsc13da.htm SC 13D/A 74148
2 EX-99.11 d750342dex9911.htm EX-99.11 7606
3 EX-99.12 d750342dex9912.htm EX-99.12 33901
4 GRAPHIC g750342001img.jpg GRAPHIC 10431
  Complete submission text file 0001193125-14-254520.txt   131716
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40724 | Film No.: 14947530
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A